HCPCS Level IIdrugActive
J1554
Inj. asceniv
BETOS: O1E
Effective: 2021-04-01
Referenced in 9 policies
Description
Injection, immune globulin (asceniv), 500 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Asceniv
Manufacturer
ADMA Biologics, Inc
HCPCS Dosage
500 MG
Billing Units
10.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.